| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |